Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6297]

EHA 2016: Restoring effective anti-tumour response in Hodgkin lymphoma with nivolumab

EHA 2016: Restoring effective anti-tumour response in Hodgkin lymphoma with nivolumab

ASCO 2016: Nivolumab extends suvival for patients with advanced kidney cancer treated beyond disease progression

ASCO 2016: Nivolumab extends suvival for patients with advanced kidney cancer treated beyond disease progression

ASCO 2016: Lenalidomide maintenance therapy improves overall survival for patients with multiple myeloma

ASCO 2016: Lenalidomide maintenance therapy improves overall survival for patients with multiple myeloma

ASCO 2016: Durvalumab monotherapy demonstrates efficacy in urothelial bladder cancer

ASCO 2016: Durvalumab monotherapy demonstrates efficacy in urothelial bladder cancer

ASCO 2016: Olaparib for patients with platinum sensitive ovarian cancer

ASCO 2016: Olaparib for patients with platinum sensitive ovarian cancer

ASCO 2016: Significant cost differences between breast cancer chemotherapy regimens identified

ASCO 2016: Significant cost differences between breast cancer chemotherapy regimens identified

Novel immunotherapy approach shows promise in blood cancers

Novel immunotherapy approach shows promise in blood cancers

A step towards a universal cancer vaccine

A step towards a universal cancer vaccine

Prevention of genetic breast cancer within reach, researchers say

Prevention of genetic breast cancer within reach, researchers say

Researchers identify protein that could prevent tumour growth in cervical cancer

Researchers identify protein that could prevent tumour growth in cervical cancer

More from ecancer